{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T19:53:09Z","timestamp":1760298789435},"reference-count":32,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2013,9,5]],"date-time":"2013-09-05T00:00:00Z","timestamp":1378339200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0074498","type":"journal-article","created":{"date-parts":[[2013,9,5]],"date-time":"2013-09-05T17:09:12Z","timestamp":1378400952000},"page":"e74498","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":20,"title":["The Co-Existence of the IL-18+183 A\/G and MMP-9 -1562 C\/T Polymorphisms Is Associated with Clinical Events in Coronary Artery Disease Patients"],"prefix":"10.1371","volume":"8","author":[{"given":"Trine B.","family":"Opstad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alf \u00c5.","family":"Pettersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harald","family":"Arnesen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingebj\u00f8rg","family":"Seljeflot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2013,9,5]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"E34","DOI":"10.1161\/hh0202.105292","article-title":"Interleukin-18 enhances atherosclerosis in apolipoprotein E(\u2212\/\u2212) mice through release of interferon-gamma","volume":"90","author":"SC Whitman","year":"2002","journal-title":"Circ Res"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1161\/hc3901.096721","article-title":"Expression of interleukin-18 in human atherosclerotic plaques and relation to plaque instability","volume":"104","author":"Z Mallat","year":"2001","journal-title":"Circulation"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"E41","DOI":"10.1161\/hh1901.098735","article-title":"Interleukin-18\/interleukin-18 binding protein signaling modulates atherosclerotic lesion development and stability","volume":"89","author":"Z Mallat","year":"2001","journal-title":"Circ Res"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.atherosclerosis.2005.02.002","article-title":"Interleukin-18: interleukin-10 ratio and in-hospital adverse events in patients with acute coronary syndrome","volume":"182","author":"GK Chalikias","year":"2005","journal-title":"Atherosclerosis"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1007\/s00125-009-1455-z","article-title":"Circulating IL-18 and the risk of type 2 diabetes in women","volume":"52","author":"MF Hivert","year":"2009","journal-title":"Diabetologia"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1097\/HJR.0b013e3282f37a6e","article-title":"Impact of inflammatory markers on cardiovascular mortality in patients with metabolic syndrome","volume":"15","author":"C Espinola-Klein","year":"2008","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"486","DOI":"10.2337\/dc08-1710","article-title":"Interleukin-18 is a strong predictor of cardiovascular events in elderly men with the metabolic syndrome: synergistic effect of inflammation and hyperglycemia","volume":"32","author":"M Troseid","year":"2009","journal-title":"Diabetes Care"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/ncpcardio1453","article-title":"The role of interleukin 18 in the pathogenesis of hypertension-induced vascular disease","volume":"6","author":"SW Rabkin","year":"2009","journal-title":"Nat Clin Pract Cardiovasc Med"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1161\/01.CIR.0000020546.30940.92","article-title":"Interleukin-18 is a strong predictor of cardiovascular death in stable and unstable angina","volume":"106","author":"S Blankenberg","year":"2002","journal-title":"Circulation"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1007\/s00508-011-0028-6","article-title":"Adipose tissue expression of interleukin-18 mRNA is elevated in subjects with metabolic syndrome and independently associated with fasting glucose","volume":"123","author":"TW Weiss","year":"2011","journal-title":"Wien Klin Wochenschr"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1161\/01.CIR.0000034509.14906.AE","article-title":"Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress","volume":"106","author":"K Esposito","year":"2002","journal-title":"Circulation"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1189\/jlb.0602313","article-title":"Interleukin-18","volume":"73(2)","author":"JA Gracie","year":"2003","journal-title":"J Leukoc Biol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.bbrc.2004.04.185","article-title":"Beta-adrenergic stimulation induces interleukin-18 expression via beta2-AR, PI3K, Akt, IKK, and NF-kappaB","volume":"319(2)","author":"B Chandrasekar","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1161\/01.RES.0000168210.10358.f4","article-title":"Angiotensin II enhances interleukin-18 mediated inflammatory gene expression in vascular smooth muscle cells: a novel cross-talk in the pathogenesis of atherosclerosis","volume":"96","author":"S Sahar","year":"2005","journal-title":"Circ Res"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1084\/jem.20011022","article-title":"Expression of interleukin (IL)-18 and functional IL-18 receptor on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for atherogenesis","volume":"195(2)","author":"N Gerdes","year":"2002","journal-title":"J Exp Med"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1161\/01.ATV.0000251503.35795.4f","article-title":"Biomarkers of atherosclerotic plaque instability and rupture","volume":"27","author":"W Koenig","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1161\/01.CIR.0000099509.76044.A2","article-title":"Interleukin-18 and the risk of coronary heart disease in European men: the Prospective Epidemiological Study of Myocardial Infarction (PRIME)","volume":"108","author":"S Blankenberg","year":"2003","journal-title":"Circulation"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1161\/ATVBAHA.109.202697","article-title":"Interleukin-18 as a predictor of future events in patients with acute coronary syndromes","volume":"30","author":"M Hartford","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/1475-2840-10-110","article-title":"Circulating levels of IL-18 are significantly influenced by the IL-18+183 A\/G polymorphism in coronary artery disease patients with diabetes type 2 and the metabolic syndrome: an observational study","volume":"10","author":"TB Opstad","year":"2011","journal-title":"Cardiovasc Diabetol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1161\/CIRCULATIONAHA.104.519702","article-title":"Genetic analysis of the interleukin-18 system highlights the role of the interleukin-18 gene in cardiovascular disease","volume":"112","author":"L Tiret","year":"2005","journal-title":"Circulation"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"15099","DOI":"10.1074\/jbc.M600200200","article-title":"Interleukin-18-induced human coronary artery smooth muscle cell migration is dependent on NF-kappaB- and AP-1-mediated matrix metalloproteinase-9 expression and is inhibited by atorvastatin","volume":"281","author":"B Chandrasekar","year":"2006","journal-title":"J Biol Chem"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.cca.2011.09.004","article-title":"Genetic variation, gene-expression and circulating levels of matrix metalloproteinase-9 in patients with stable coronary artery disease","volume":"413","author":"TB Opstad","year":"2012","journal-title":"Clin Chim Acta"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1161\/01.CIR.0000058700.41738.12","article-title":"Plasma concentrations and genetic variation of matrix metalloproteinase 9 and prognosis of patients with cardiovascular disease","volume":"107","author":"S Blankenberg","year":"2003","journal-title":"Circulation"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1161\/01.CIR.99.14.1788","article-title":"Functional polymorphism in the regulatory region of gelatinase B gene in relation to severity of coronary atherosclerosis","volume":"99","author":"B Zhang","year":"1999","journal-title":"Circulation"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1080\/14017430410024324","article-title":"Unstable angina, stroke, myocardial infarction and death in aspirin non-responders. A prospective, randomized trial. The ASCET (ASpirin non-responsiveness and Clopidogrel Endpoint Trial) design","volume":"38","author":"AA Pettersen","year":"2004","journal-title":"Scand Cardiovasc J"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"e000703","DOI":"10.1161\/JAHA.112.000703","article-title":"High On-Aspirin Platelet Reactivity and Clinical Outcome in Patients With Stable Coronary Artery Disease: Results From ASCET (Aspirin Nonresponsiveness and Clopidogrel Endpoint Trial)","volume":"1","author":"AA Pettersen","year":"2012","journal-title":"J Am Heart Assoc"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.atherosclerosis.2007.07.018","article-title":"Interleukin-18 promoter polymorphism associates with the occurrence of sudden cardiac death among Caucasian males: the Helsinki Sudden Death Study","volume":"196","author":"JA Hernesniemi","year":"2008","journal-title":"Atherosclerosis"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s00210-002-0648-5","article-title":"IL-18 initiates release of matrix metalloproteinase-9 from peripheral blood mononuclear cells without affecting tissue inhibitor of matrix metalloproteinases-1: suppression by TNF alpha blockage and modulation by IL-10","volume":"367","author":"M Nold","year":"2003","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1365-2567.2007.02728.x","article-title":"Comparison of MMP-2 and MMP-9 secretion from T helper 0, 1 and 2 lymphocytes alone and in coculture with macrophages","volume":"124","author":"E Oviedo-Orta","year":"2008","journal-title":"Immunology"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.ijcard.2007.04.107","article-title":"A close relationship between functional polymorphism in the promoter region of matrix metalloproteinase-9 and acute myocardial infarction","volume":"127","author":"YS Koh","year":"2008","journal-title":"Int J Cardiol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1161\/01.ATV.0000135656.49158.95","article-title":"Matrix metalloproteinase-9 genotype influences large artery stiffness through effects on aortic gene and protein expression","volume":"24","author":"TL Medley","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.ehj.2004.01.015","article-title":"Prognostic impact of matrix metalloproteinase gene polymorphisms in patients with heart failure according to the aetiology of left ventricular systolic dysfunction","volume":"25","author":"F Mizon-Gerard","year":"2004","journal-title":"Eur Heart J"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0074498","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T02:32:14Z","timestamp":1540261934000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0074498"}},"subtitle":[],"editor":[{"given":"Renate B.","family":"Schnabel","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2013,9,5]]},"references-count":32,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2013,9,5]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0074498","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,9,5]]}}}